Mark D. Black

1.1k total citations
28 papers, 958 citations indexed

About

Mark D. Black is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, Mark D. Black has authored 28 papers receiving a total of 958 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Cellular and Molecular Neuroscience, 14 papers in Molecular Biology and 7 papers in Physiology. Recurrent topics in Mark D. Black's work include Neuroscience and Neuropharmacology Research (18 papers), Receptor Mechanisms and Signaling (9 papers) and Neurotransmitter Receptor Influence on Behavior (9 papers). Mark D. Black is often cited by papers focused on Neuroscience and Neuropharmacology Research (18 papers), Receptor Mechanisms and Signaling (9 papers) and Neurotransmitter Receptor Influence on Behavior (9 papers). Mark D. Black collaborates with scholars based in United States, United Kingdom and France. Mark D. Black's co-authors include Yossef Itzhak, Julio L. Martin, P.P.A. Humphrey, Syed F. Ali, Joseph G. Wettstein, Paul L. Huang, Guy Griebel, Stephen M. Sorensen, Ina Weiner and Michal Arad and has published in prestigious journals such as Scientific Reports, Brain Research and Annals of the New York Academy of Sciences.

In The Last Decade

Mark D. Black

28 papers receiving 943 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark D. Black United States	17	595	437	159	117	112	28	958
Laura Lambás‐Señas France	18	687 1.2×	396 0.9×	145 0.9×	111 0.9×	183 1.6×	36	1.1k
Dinah Weissmann France	21	640 1.1×	474 1.1×	139 0.9×	84 0.7×	88 0.8×	53	1.1k
Jun’ichi Semba Japan	19	508 0.9×	376 0.9×	122 0.8×	67 0.6×	76 0.7×	42	897
Franćoise Lejeune France	21	881 1.5×	623 1.4×	102 0.6×	162 1.4×	147 1.3×	33	1.3k
Hideko Yamamoto Japan	21	794 1.3×	588 1.3×	174 1.1×	65 0.6×	97 0.9×	50	1.2k
C M Fattaccini France	14	866 1.5×	527 1.2×	198 1.2×	127 1.1×	130 1.2×	15	1.1k
Denis Boulay France	15	587 1.0×	410 0.9×	76 0.5×	96 0.8×	80 0.7×	23	816
Philip A. Iredale United States	18	511 0.9×	464 1.1×	95 0.6×	120 1.0×	229 2.0×	30	1.1k
Vicky Holland United Kingdom	11	584 1.0×	369 0.8×	89 0.6×	83 0.7×	95 0.8×	13	988
Laura M. Gault United States	16	431 0.7×	349 0.8×	180 1.1×	90 0.8×	174 1.6×	24	1.0k

Countries citing papers authored by Mark D. Black

Since Specialization

Citations

This map shows the geographic impact of Mark D. Black's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark D. Black with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark D. Black more than expected).

Fields of papers citing papers by Mark D. Black

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark D. Black. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark D. Black. The network helps show where Mark D. Black may publish in the future.

Co-authorship network of co-authors of Mark D. Black

This figure shows the co-authorship network connecting the top 25 collaborators of Mark D. Black. A scholar is included among the top collaborators of Mark D. Black based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark D. Black. Mark D. Black is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Griebel, Guy, Philippe Pichat, Denis Boulay, et al.. (2016). The mGluR2 positive allosteric modulator, SAR218645, improves memory and attention deficits in translational models of cognitive symptoms associated with schizophrenia. Scientific Reports. 6(1). 35320–35320. 40 indexed citations

Black, Mark D., Robert E. Featherstone, Yaw Senyah, et al.. (2010). AVE1625, a cannabinoid CB1 receptor antagonist, as a co-treatment with antipsychotics for schizophrenia: improvement in cognitive function and reduction of antipsychotic-side effects in rodents. Psychopharmacology. 215(1). 149–163. 41 indexed citations

Barak, Segev, et al.. (2009). Pro-Cognitive and Antipsychotic Efficacy of the α7 Nicotinic Partial Agonist SSR180711 in Pharmacological and Neurodevelopmental Latent Inhibition Models of Schizophrenia. Neuropsychopharmacology. 34(7). 1753–1763. 44 indexed citations

Black, Mark D., Geoffrey B. Varty, Michal Arad, et al.. (2008). Procognitive and antipsychotic efficacy of glycine transport 1 inhibitors (GlyT1) in acute and neurodevelopmental models of schizophrenia: latent inhibition studies in the rat. Psychopharmacology. 202(1-3). 385–396. 68 indexed citations

Maynard, Kenneth I., Stacey J. Sukoff Rizzo, Zhongqi Ji, Joseph G. Wettstein, & Mark D. Black. (2005). The acoustic startle reflex in Sprague-Dawley rats is altered by permanent middle cerebral artery occlusion. Brain Research. 1032(1-2). 44–49. 1 indexed citations

Zhu, Bin, et al.. (2004). An Electrophysiological Model of Spinal Transmission Deficits in Mouse Experimental Autoimmune Encephalomyelitis. Journal of Pharmacology and Experimental Therapeutics. 308(1). 214–220. 4 indexed citations

Wettstein, Joseph G., et al.. (2003). Comparative analysis of acute and chronic administration of haloperidol and clozapine using [3H] 2-deoxyglucose metabolic mapping. Schizophrenia Research. 61(2-3). 195–205. 10 indexed citations

Black, Mark D., et al.. (2002). Neonatal nitric oxide synthase inhibition: social interaction deficits in adulthood and reversal by antipsychotic drugs. Neuropharmacology. 42(3). 414–420. 29 indexed citations

Black, Mark D., et al.. (2000). Effect of AMPA receptor modulators on hippocampal and cortical function. European Journal of Pharmacology. 394(1). 85–90. 13 indexed citations

10.

Black, Mark D., David E. Selk, Janice M. Hitchcock, Joseph G. Wettstein, & Stephen M. Sorensen. (1999). On the effect of neonatal nitric oxide synthase inhibition in rats: a potential neurodevelopmental model of schizophrenia. Neuropharmacology. 38(9). 1299–1306. 67 indexed citations

11.

Ali, Syed F., et al.. (1999). Neuroprotective Role of Melatonin in Methamphetamine‐ and 1‐Methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐induced Dopaminergic Neurotoxicity. Annals of the New York Academy of Sciences. 890(1). 119–119. 11 indexed citations

12.

Itzhak, Yossef, Julio L. Martin, Mark D. Black, & Syed F. Ali. (1999). Effect of the Dopaminergic Neurotoxin MPTP on Cocaine-Induced Locomotor Sensitization. Pharmacology Biochemistry and Behavior. 63(1). 101–107. 20 indexed citations

13.

Itzhak, Yossef, Syed F. Ali, Julio L. Martin, Mark D. Black, & Paul L. Huang. (1998). Resistance of neuronal nitric oxide synthase-deficient mice to cocaine-induced locomotor sensitization. Psychopharmacology. 140(3). 378–386. 54 indexed citations

14.

Itzhak, Yossef, Julio L. Martin, Mark D. Black, & Paul L. Huang. (1998). The role of neuronal nitric oxide synthase in cocaine-induced conditioned place preference. Neuroreport. 9(11). 2485–2488. 62 indexed citations

15.

Stewart, Tracy L., Anton D. Michel, Mark D. Black, & P.P.A. Humphrey. (1996). Evidence that Nitric Oxide Causes Calcium‐Independent Release of [³H]Dopamine from Rat Striatum In Vitro. Journal of Neurochemistry. 66(1). 131–137. 60 indexed citations

16.

Chessell, Iain P., Mark D. Black, W. Feniuk, & P.P.A. Humphrey. (1996). Operational characteristics of somatostatin receptors mediating inhibitory actions on rat locus coeruleus neurones. British Journal of Pharmacology. 117(8). 1673–1678. 28 indexed citations

17.

Black, Mark D., A.R. Crossman, Ann G. Hayes, & Peter J. Elliott. (1994). Acute and chronic behavioural sequelae resulting from intrastriatal injection of an NMDA agonist. Pharmacology Biochemistry and Behavior. 48(2). 441–446. 6 indexed citations

18.

Black, Mark D. & John Kinsella. (1993). Dietary n-3 Fatty Acids Alter Murine Peritoneal Macrophage Cytotoxicity. Annals of Nutrition and Metabolism. 37(3). 110–120. 10 indexed citations

19.

Black, Mark D. & Alan R. Crossman. (1992). Changes in dopamine D1 and D2 receptor binding in the substantia nigra following intrastriatal injection of a retrograde neurotoxin (volkensin). Neuroscience Letters. 134(2). 180–182. 11 indexed citations

20.

Black, Mark D., F. Carey, A.R. Crossman, Jane K. Relton, & Nancy J. Rothwell. (1992). Lipocortin-1 inhibits NMDA receptor-mediated neuronal damage in the striatum of the rat. Brain Research. 585(1-2). 135–140. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact